LBO — PARIS REGIONAL MEDICAL CENTER
IRR: 22.6% | MOIC: 2.77x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
22.6%
IRR
2.77x
MOIC
$64.9M
Entry EV
$122.3M
Exit EV
$33.4M
Equity Invested
Sources & Uses
S&UTotal · $64.9M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $25.2M | 38.8% | |
| Sub Debt | $6.3M | 9.7% | |
| Equity | $33.4M | 51.5% | |
| Enterprise Value | $63.0M | 97.1% | |
| Transaction Fees | $1.9M | 2.9% | |
| Total Uses | $64.9M | 100.0% |
Interpretation
INTAt 2.77x MOIC and 22.6% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $11.6M |
| Exit Ev | $122.3M |
| Net Debt At Exit | $29.9M |
| Equity At Exit | $92.4M |
| Equity Invested | $33.4M |
| Total Value Created | $59.1M |
| Value From Growth | $56.2M |
| Value From Multiple | $3.1M |
| Value From Deleveraging | $1.6M |